March 28, 2026 — Medtronic has announced the EMBRACE trial, led by Dr. Roxana Mehran, Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute at the Icahn School of Medicine at Mount Sinai, and Dr. Felix Mahfoud, Professor of Cardiology at the University of Basel and Chief of Cardiology at the University Hospital Basel.

March 28, 2026 — Randomized controlled trial (RCT) data presented at the American College of Cardiology (ACC) 2026 and simultaneously published in the Journal of the American College of Cardiology demonstrates for the first time that supporting the left ventricle (LV) with an Impella CP for more than 40 minutes prior to reperfusion does not reduce nor increase heart muscle damage, known as a myocardial infarction. Greater infarct size correlates to a higher risk of dying or developing heart failure, a condition that impacts more than 55 million worldwide1.

March 26, 2026 —The heart’s ability to use oxygen efficiently is a critical indicator of its health, but tests to measure this function have drawbacks that can limit their use. A new Cedars-Sinai Health Sciences University study found that a new MRI system developed at Cedars-Sinai might overcome this challenge.

March 25, 2026 — Royal Philips has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that assists physicians during one of interventional cardiology’s most technically demanding procedures – repairing leaking mitral valves through a minimally invasive approach. 

March 25, 2026 — At the 75th Annual Scientific Session & Expo of the American College of Cardiology (ACC.26) in New Orleans, Cleerly will launch Cleerly PREVIEW, a new workflow-support enhancement designed to assist clinicians with case prioritization and streamline administrative processes, such as prior authorization, for coronary artery disease (CAD) imaging.

March 25,  2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets cardiac MRI scans with performance approaching expert clinicians. Trained on more than 300,000 MRI video clips from roughly 20,000 patients, the model can assess heart function and diagnose dozens of diseases using only non‑contrast imaging. The work was published in Nature Biomedical Engineering.

March 18, 2026  — UltraSight will present six clinical studies validating the performance of its UltraSight Echosystem at the 2026 American College of Cardiology’s Annual Scientific Session & Expo (ACC.26). The studies, conducted in collaboration with Mayo Clinic, confirm that the UltraSight Echosystem enables healthcare professionals without prior sonography training to acquire diagnostic-quality cardiac ultrasound images with greater than 95% accuracy across multiple patient populations and care settings.

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is cleared for clinical use in the U.S. and Europe. With CE marking and FDA 510(k) clearance, the redesigned platform combines the most comprehensive diagnostic and treatment planning tools to deliver efficiency, simplicity and precision in a single intuitive system1.

March 24, 2026 — Physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will present research and clinical insights during the American College of Cardiology’s Annual Scientific Session, March 28-30 in New Orleans.

Late-Breaking Science

March 24, 2026 — Physician-scientists from RWJBarnabas Health and Rutgers Health will present a dynamic portfolio of cardiovascular research at the American College of Cardiology's Annual Scientific Session & Expo (ACC.26), in New Orleans, LA, March 28–30, 2026. Seventy abstracts have been accepted, highlighting clinical insights and emerging science designed to advance prevention strategies, refine treatment approaches and improve outcomes for patients with cardiovascular disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now